The Federal University of Minas Gerais is a federal research university located in the state of Minas Gerais. Its main and biggest campus is located at the city of Belo Horizonte, Brazil. It is one of Brazil's five largest and best universities, being the largest federal university.

During the past decade, SOM Federal University Minas Gerais Brazil NICHD CRS conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "SOM Federal University Minas Gerais Brazil NICHD CRS" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "International Maternal Pediatric Adolescent AIDS Clinical Trials Group" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "SOM Federal University Minas Gerais Brazil NICHD CRS" are "COVID-19" (1 trials), "HIV Infections" (1 trials), "SARS-CoV-2" (1 trials) and "Tuberculosis" (1 trials). Many other conditions were trialed in "SOM Federal University Minas Gerais Brazil NICHD CRS" in a lesser frequency.

Most popular intervention types in "SOM Federal University Minas Gerais Brazil NICHD CRS" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atazanavir/ritonavir (ATV/r)" (1 trials), "Bictegravir (BIC)" (1 trials), "Cabotegravir (CAB)" (1 trials), "Cobicistat" (1 trials) and "Darunavir/ritonavir (DRV/r)" (1 trials). Other intervention names were less common.

The vast majority of trials in "SOM Federal University Minas Gerais Brazil NICHD CRS" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "SOM Federal University Minas Gerais Brazil NICHD CRS". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in SOM Federal University Minas Gerais Brazil NICHD CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SOM Federal University Minas Gerais Brazil NICHD CRS, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".